Meeting of the Parliament 11 March 2026 [Draft]
To answer Ruth Maguire’s first point, yes, I share her concerns. There is perhaps an issue about public awareness, but there is also an issue about the lack of research that has been undertaken into the reliability of drugs that are used in assisted dying. For example, a recent article in the Journal of Law and the Biosciences set out that point very clearly. I share the member’s concerns.
Although amendment 224 would not address all issues relating to complications, it would make the identification of trends in complications more possible. The recording of basic information on what drugs are used is a necessary step in firming up accountability and prioritising patient safety. I therefore urge members to support amendment 224.